01 2AVELUMAB
02 2CETRORELIX ACETATE
03 2CHORIOGONADOTROPIN ALFA
04 1CLADRIBINE
05 1CLOMIPHENE CITRATE
06 12FOLLITROPIN ALFA/BETA
07 23LEVOTHYROXINE SODIUM
08 7METFORMIN HYDROCHLORIDE
09 3MITOXANTRONE HYDROCHLORIDE
10 3SERMORELIN ACETATE
11 9SOMATROPIN
12 4SOMATROPIN RECOMBINANT
13 1TEPOTINIB HYDROCHLORIDE
01 20INJECTABLE;INJECTION
02 1INJECTABLE;INTRAVENOUS
03 14INJECTABLE;SUBCUTANEOUS
04 2POWDER;SUBCUTANEOUS
05 2TABLET, EXTENDED RELEASE;ORAL
06 31TABLET;ORAL
01 20.025MG
02 20.05MG
03 20.075MG
04 20.088MG
05 20.112MG
06 20.125MG
07 10.137MG
08 20.15MG
09 20.175MG
10 20.1MG
11 10.25MG/VIAL
12 20.2MG
13 20.3MG
14 11,050 IU/VIAL
15 110MG
16 1150 IU/0.25ML
17 2150 IU/VIAL
18 11GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 220MG/ML
20 1300 IU/0.5ML
21 237.5 IU/VIAL
22 1450 IU/0.75ML
23 1450 IU/VIAL
24 34MG/VIAL
25 2500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
26 150MG
27 35MG/VIAL
28 1625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
29 16MG/0.5ML (6MG/0.5ML)
30 36MG/VIAL
31 275 IU/VIAL
32 2750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
33 38.8MG/VIAL
34 1850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
35 1900 IU/1.5ML
36 1EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
37 1EQ 0.25MG /0.5ML
38 1EQ 0.25MG BASE/VIAL
39 1EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
40 1EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
41 1EQ 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
42 1EQ 225MG BASE
43 1EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
44 1EQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
45 1EQ 3MG BASE/VIAL
01 38DISCN
02 3RX
03 29Blank
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : BAVENCIO
Dosage Strength : 20MG/ML
Approval Date :
Application Number : 761049
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INTRAVENOUS
Proprietary Name : BAVENCIO
Dosage Strength : 20MG/ML
Approval Date :
Application Number : 761078
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code : AP
Dosage Form : POWDER; SUBCUTANEOUS
Proprietary Name : CETROTIDE
Dosage Strength : EQ 0.25MG BASE/VIAL
Approval Date : 2000-08-11
Application Number : 21197
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : Yes
TE Code :
Dosage Form : POWDER; SUBCUTANEOUS
Proprietary Name : CETROTIDE
Dosage Strength : EQ 3MG BASE/VIAL
Approval Date : 2000-08-11
Application Number : 21197
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : OVIDREL
Dosage Strength : 0.25MG/VIAL
Approval Date :
Application Number : 21149
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; SUBCUTANEOUS
Proprietary Name : OVIDREL
Dosage Strength : EQ 0.25MG /0.5ML
Approval Date :
Application Number : 21149
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : MAVENCLAD
Dosage Strength : 10MG
Approval Date : 2019-03-29
Application Number : 22561
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : SEROPHENE
Dosage Strength : 50MG
Approval Date : 1982-03-22
Application Number : 18361
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; SUBCUTANEOUS
Proprietary Name : GONAL-F
Dosage Strength : 37.5 IU/VIAL
Approval Date :
Application Number : 21765
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; SUBCUTANEOUS
Proprietary Name : GONAL-F RFF
Dosage Strength : 75 IU/VIAL
Approval Date :
Application Number : 21765
RX/OTC/DISCN :
RLD :
TE Code :
